Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.11.09
Superior Gr of Cos Q3 EPS $0.17 Misses $0.18 Estimate, Sales $145.994M Beat $143.483M Estimate
Benzinga
2026.11.09
Superior Gr of Cos Raises FY2026 GAAP EPS Guidance from $0.54-$0.66 to $0.60-$0.66 vs $0.56 Est; Raises FY2026 Sales Guidance from $572.000M-$585.000M to $578.000M-$585.000M vs $583.560M Est
Benzinga
2026.11.09
Cantor Fitzgerald Maintains Neutral on Home BancShares, Raises Price Target to $32
Benzinga
2026.11.09
Keefe, Bruyette & Woods Maintains Market Perform on American Financial Group, Raises Price Target to $150
Benzinga
2026.11.09
Novocure Receives Not Approvable Letter From FDA In Response To PMA Application For Optune Mya For Treatment Of Adult Patients With Brain Metastases From Non-Small Cell Lung Cancer Following Stereotactic Radiation
Benzinga
2026.11.09
11 Information Technology Stocks Moving In Monday's Pre-Market Session
Benzinga
2026.11.09
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session
Benzinga
2026.11.09
SPA
12 Industrials Stocks Moving In Monday's Pre-Market Session
Benzinga
2026.11.09
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga
2026.11.09
Kamada Q3 EPS $0.14 Beats $0.13 Estimate, Sales $52.034M Miss $52.506M Estimate
Benzinga
2026.11.09
Cantor Fitzgerald Maintains Overweight on Block, Raises Price Target to $102
Benzinga
2026.11.09
Ionis Pharmaceuticals Q3 Adj. EPS $(0.40) Beats $(1.21) Estimate, Sales $243.000M Beat $182.117M Estimate
Benzinga
2026.11.09
Via Transportation Q3 Adj. EPS $0.00 Beats $(0.02) Estimate, Sales $143.528M Beat $137.937M Estimate
Benzinga
2026.11.09
PowerFleet Affirms FY2026 Sales Guidance of $468.000M-$473.000M vs $469.008M Est
Benzinga
2026.11.09
Tonix Pharmaceuticals Q3 EPS $(2.89) Misses $(2.31) Estimate, Sales $17.200M Beat $16.717M Estimate
Benzinga
2026.11.09
Cantor Fitzgerald Reiterates Underweight on Western Union, Maintains $6 Price Target
Benzinga
2026.11.09
TG Therapeutics Raises FY2026 Sales Guidance from $950.000M to $1.000B vs $960.306M Est
Benzinga
2026.11.09
Hain Celestial Group Q1 Adj. EPS $(0.07) Misses $(0.03) Estimate, Sales $260.724M Miss $283.031M Estimate
Benzinga
2026.11.09
Neuraxis Q3 EPS $(0.52) Misses $(0.34) Estimate, Sales $2.028M Miss $2.300M Estimate
Benzinga
2026.11.09
Fervo Energy Q3 EPS $(0.07) Beats $(0.09) Estimate, Sales $116.000K Miss $165.375K Estimate
Benzinga
2026.11.09
Kamada Raises FY2026 Sales Guidance from $200.000M-$205.000M to $205.000M-$208.000M vs $202.960M Est
Benzinga
2026.11.09
TG Therapeutics Q3 EPS $0.35 Beats $0.34 Estimate, Sales $259.936M Beat $245.475M Estimate
Benzinga
2026.11.09
Via Transportation Raises FY2026 Sales Guidance from $550.000M-$553.000M to $556.700M-$558.400M vs $551.736M Est
Benzinga
2026.11.09
Via Transportation Sees Q4 Sales $150.000M-$151.700M vs $150.689M Est
Benzinga
2026.11.09
PowerFleet Q2 Adj. EPS $0.04 Beats $(0.03) Estimate, Sales $115.723M Beat $114.919M Estimate
Benzinga
2026.11.09
Cantor Fitzgerald Reiterates Overweight on Remitly Global, Maintains $30 Price Target
Benzinga
2026.11.09
Ionis Pharmaceuticals Affirms FY2026 Sales Guidance of $875.000M-$900.000M vs $916.396M Est
Benzinga
2026.11.09
CEVA Q3 Adj. EPS $0.13 Misses $0.19 Estimate, Sales $29.100M Miss $32.708M Estimate
Benzinga
2026.11.09
CECO Environmental Q3 Adj. EPS $0.60 Misses $0.83 Estimate, Sales $404.428M Beat $208.104M Estimate
Benzinga
2026.11.09
CECO Environmental Affirms FY2026 Sales Guidance of $1.300B-$1.375B vs $1.103B Est
Benzinga
1
...
157
158
159
160
161
162
...
712
>